Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones Contineum Therapeutics, Inc. a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today reported its second-quarter 2026 financial results…
Feinstein Institutes’ scientists identify the brain’s breathing ‘alarm system’ Beyond automatic breathing reflexes, new research out of Northwell Health’s Feinstein Institutes for Medical Research discovered a brain circuit that keeps track of every inhale and exhale, explaining critical differences in how we perceive,…
ADM to Expand North America Crush Capacity Amid Strong Biofuel Demand ADM a global leader in innovative solutions from nature, announced a series of investments designed to expand North American oilseed crush capacity and strengthen the company’s ability to meet…
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union Pfizer Inc. and BioNTech SE announced today that the European Commission (EC) has granted marketing authorization for the companies’ 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, for active…
Eastern Technologies Launches COOLGARD Non-Phosphorus Chemistry Line for Industrial Cooling Water Eastern Technologies, Inc. a Sylmar company and custom formulator of industrial water treatment chemistries, today announced the launch of its COOLGARD Non-Phosphorus product line. The line gives ETI’s partners…
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, announced data to be presented this…
Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026 Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association…
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies…
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development Merck known as MSD outside of the United States and Canada, announced early components of a multi-faceted strategy to provide rapid, broad and sustainable…
Enhertu® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been recommended for approval in the European Union (EU) for the first-line…
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI MindWalk Holdings Corp. a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s…
Vultr and AMD Support the University of Cambridge’s TESSERA AI Project to Accelerate Global Environmental Monitoring Vultr, the world’s largest privately-held cloud infrastructure company, and AMD, a leader in high-performance and AI computing, have announced their support for the University of…